← Search & browse all drugs
RESPIRATORY SYSTEM › ANTIHISTAMINES FOR SYSTEMIC USE › ANTIHISTAMINES FOR SYSTEMIC USE › Phenothiazine derivatives
thiazinam
R06AD06
Forms & Strengths
- Oral tablets 10 mg
- Oral syrup 1 mg/mL
Adult Dosing
- 10 mg 3‑4 times daily (max 40 mg/day) for allergic rhinitis/urticaria
- 5 mg twice daily in elderly or hepatic impairment
Pediatric Dosing
- 0.25‑0.5 mg/kg per dose every 6‑8 h, not exceeding 10 mg/day
- Syrup: 1 mL (1 mg) q6‑8 h for children ≥12 kg
Indications
- Allergic rhinitis
- Acute urticaria
- Pruritus from insect bites
- Mild atopic dermatitis
Mechanism of Action
- Competitive peripheral H1‑histamine receptor antagonist
- Crosses BBB → central sedation
- Weak anticholinergic activity
Contraindications
- Hypersensitivity to thiazinam or related piperazine antihistamines
- Narrow‑angle glaucoma
- Severe urinary retention/prostatic hypertrophy
- Pregnancy category C – avoid if possible
Adverse Reactions
- Sedation, somnolence, dizziness
- Dry mouth, blurred vision, constipation (anticholinergic)
- Weight gain, increased appetite
- Tachycardia, hypotension
- Rare rash or hepatic enzyme elevation
Drug Interactions
- Additive CNS depression with alcohol, benzodiazepines, opioids, other antihistamines
- Reduced clearance with CYP2D6 inhibitors (e.g., fluoxetine)
- Enhanced anticholinergic load with TCAs, other antihistamines
- May potentiate antihypertensives (alpha‑blockers) causing hypotension
Curated Content: Needs Vetting Before Put to Clinical Use